Aleksandra E. Paltseva

Aleksandra E. Paltseva

Auto-generated profile, based on publicly available information

Aleksandra E. Paltseva

Morozov Children’s City Clinical Hospital; Scientific Research Clinical Institute of Childhood

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Pediatric pharmacology
Verified
Journal Article
Open access
PDF file
OKO. V. Kozhevnikova
O. V. Kozhevnikova
LNLeyla S. Namazova-Baranova
Leyla S. Namazova-Baranova
YMYu. S. Mytnikova
Yu. S. Mytnikova
EAE. A. Abashidze
E. A. Abashidze
TMT. V. Margieva
T. V. Margieva
APA. E. Paltseva
A. E. Paltseva
ОЖИРЕНИЕ И НАРУШЕНИЯ СНА У ДЕТЕЙ

19 January 2022 in Russian Pediatric Journal
Verified
Journal Article
Open access
OKOlga V. Kozhevnikova
Olga V. Kozhevnikova
EAEka A. Abashidze
Eka A. Abashidze
AFAndrey P. Fisenko
Andrey P. Fisenko
EAElina E. Akhmedova
Elina E. Akhmedova
OLOlga S. Logacheva
Olga S. Logacheva
APAnastasiya S. Polyakova
Anastasiya S. Polyakova
Introduction. Currently, there is an increase in the incidence and an increase in the severity of the course of COVID-19 in children. The tropism of the SARS-CoV-2 virus to the cardiovascular system has been established, while post-COVID syndrome with various manifestations is recorded in 25% of recovered adolescents. The purpose of the work was to identify the features of the electrocardiogram (ECG) pattern in children hospitalized with a diagnosis of COVID-19. Results. Significant changes in the conductivity and activity of the left heart myocardium were found in COVID-19 patients with pneumonia and respiratory failure. Pronounced changes in ECG indices were found in children of senior school age who were admitted for treatment 2.4 times more often than other children. Proarrhythmogenic ECG indices in children were detected in severe COVID-19 - with community-acquired pneumonia (ΔQTc, QTcmin) and respiratory failure (TpTe/QTmax). These ECG changes, combined with the trend in inflammation markers (an increase in the C-reactive protein level and a decrease in the number of lymphocytes) in children with a moderate course of COVID-19 may be a sign of the involvement of the myocardium in an infectious inflammatory process. This suggests that the effect on the myocardium is exerted by systemic inflammation and not by the hemodynamic overload of the right heart, which is expected in pulmonary pathology. Conclusion. The obtained data indicate the need for dynamic ECG monitoring during the acute stage of the disease and rehabilitation of children who suffered from COVID-19.

14 August 2026 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
YCYu.V. Chernenkov
Yu.V. Chernenkov
OGO.I. Gumeniuk
O.I. Gumeniuk
EBE.V. Balashova
E.V. Balashova
IGI.V. Goremykin
I.V. Goremykin
IDI.S. Davydov
I.S. Davydov
DODmitry Ovsyannikov
Dmitry Ovsyannikov
Pulmonary epithelioid hemangioendothelioma (PEH) is a rare vascular neoplasm of intermediate malignancy characterized by a highly variable clinical course and significant diagnostic challenges. In pediatric practice, the incidence of this condition is extremely low, which often leads to diagnostic errors, particularly in cases with atypical molecular variants. Objective: To demonstrate the clinical, instrumental, and morphological features of pulmonary epithelioid hemangioendothelioma in children and to highlight the challenges of differential diagnosis. Materials and Methods: We present a clinical case of a 14-year-old adolescent with bilateral diffuse lung involvement who underwent a comprehensive diagnostic evaluation, including chest computed tomography, bronchoscopy with biopsy, histological and immunohistochemical analysis, as well as lung function testing. Results: Multiple bilateral pulmonary nodules were identified, while no significant functional impairment was observed. The initial histological findings were consistent with organizing pneumonia. The differential diagnosis included tuberculosis, sarcoidosis, pulmonary alveolar proteinosis, and IgG4-related lung disease. The final diagnosis was established after expert histopathological review, revealing features of PEH with positive expression of endothelial markers (CD31, CD34, ERG) and absence of CAMTA1 and TFE3 expression. This pattern does not correspond to the typical molecular variants observed in the majority of cases and underscores the molecular heterogeneity of the tumor. Conclusion: This case demonstrates that PEH may mimic inflammatory lung diseases and be associated with negative results for key molecular markers (CAMTA1, TFE3). Accurate diagnosis requires a comprehensive approach, including detailed histological and immunohistochemical evaluation. Awareness of this entity in the differential diagnosis of diffuse lung diseases in children may reduce the risk of diagnostic errors and highlights the importance of a multidisciplinary approach involving pediatricians, pulmonologists, oncologists, and pathologists.

14 October 2026 in Pediatrics. Consilium Medicum
Verified
Journal Article
Open access
PDF file
OMOleg G. Malyshev
Oleg G. Malyshev
МГМалышев Олег Геннадьевич
Малышев Олег Геннадьевич
SGShamil' A. Gitinov
Shamil' A. Gitinov
ГАГитинов Шамиль Абдулвахидович
Гитинов Шамиль Абдулвахидович
TKTatiana A. Krashilina
Tatiana A. Krashilina
ОЮОвсянников Дмитрий Юрьевич
Овсянников Дмитрий Юрьевич
Background. Idiopathic pulmonary hemosiderosis (IPH) is a rare interstitial lung disease associated with recurrent diffuse alveolar hemorrhage, anemia, and the risk of pulmonary fibrosis. Aim. To describe the clinical and laboratory, computed tomographic, diagnostic, therapeutic characteristics and outcomes of children with IPH. Materials and methods. This ambispective descriptive multicenter study included 11 patients with disease onset before 18 years of age and pulmonary hemorrhage/hemosiderosis documented by bronchoscopy with bronchoalveolar lavage, cytological and/or morphological examination, after exclusion of alternative causes. Clinical history, laboratory and instrumental findings, treatment, and outcomes were evaluated. Results. The cohort included 5 boys and 6 girls. The median age at IPH onset was 6.0 [3.7; 8.6] years, the median age at diagnosis was 8.0 [4.9; 9.7] years, the median diagnostic delay was 4.9 [1.8; 22.8] months, and the median minimum hemoglobin level was 52 [38.5; 98.5] g/L (data available for 10 patients). Anemia was documented in all patients, and hemoptysis in 6/11 (55%). Signs of diffuse lung involvement on chest CT were present in all patients; ground-glass opacities and consolidation were the most common findings. Six patients required ICU care, 3 required mechanical ventilation, and 8 received red blood cell transfusions. All patients received systemic glucocorticoids; azathioprine was used in 5, rituximab in 4, and cyclophosphamide in 1 patient. Three patients died. Conclusion. IPH debuts anemia in children. The absence of hemoptysis does not exclude diffuse alveolar hemorrhage. Early computed tomography of the chest organs, bronchoscopy with bronchoalveolar lavage, the search for siderophages and the exclusion of secondary causes are the key stages of diagnosis. In severe and recurrent cases, multidisciplinary management and steroid-sparing immunosuppressive therapy are required.

1 January 2019 in Voprosy praktičeskoj pediatrii
Verified
Journal Article
Closed access
IFI.K. Filimonova
I.K. Filimonova
OKO.V. Kozhevnikova
O.V. Kozhevnikova
MIM.I. Ivardava
M.I. Ivardava
APA.E. Paltseva
A.E. Paltseva
OLO.S. Logacheva
O.S. Logacheva
KEK.A. Eletskaya
K.A. Eletskaya